Publication | Closed Access

Magnetic resonance spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas

Pituitary GlandGrowth HormoneHuman GrowthMagnetic Resonance SpectroscopyNeuroendocrine DisorderGynecologyPresurgical PredictorPituitary DiseaseEndocrinologyMedicineReproductive Endocrinology